Evaluation of the results of the patients who underwent plasmapheresis in the pediatric intensive care unit.
Therapeutic plasma exchange
mortality
multisystem inflammatory syndrome
pediatric intensive care unit
Journal
Turkish journal of medical sciences
ISSN: 1303-6165
Titre abrégé: Turk J Med Sci
Pays: Turkey
ID NLM: 9441758
Informations de publication
Date de publication:
2024
2024
Historique:
received:
08
10
2023
revised:
12
06
2024
accepted:
04
03
2024
medline:
26
7
2024
pubmed:
26
7
2024
entrez:
25
7
2024
Statut:
epublish
Résumé
Therapeutic plasma exchange (TPE) is an extracorporeal treatment method that removes large molecular weight substances from plasma. In our study, we aimed to retrospectively examine the indications and procedural methods of the patients who had undergone TPE, and the complications that occurred during the procedure. Forty-one patients who were monitored in thePICU of Gazi Yaşargil Training and Research Hospital and had indications for TPE between 2017 and 2021 were included in the study. Laboratory parameters were checked before and after the TPE procedure. In addition to these, patients' diagnosis, weight, type of procedure and type of device, where the procedure was performed, duration of the procedure, amount of blood and plasma processed, complications, number of procedures, and death during the procedure or independent of the procedure were evaluated. The median age was 93.0 (14.0-167.0) months. Hemolytic uremic syndrome (HUS) was the most common TPE indication with nine patients. The most common complication related to TPE was fever (11 patients), while no complication was observed in 18 patients.When laboratory results were evaluated according to American Society for Apheresis (ASFA) categories, a significant improvement was observed in the values of platelet, AST, ALT, LDH, urea, and creatinine in ASFA1 after TPE. No significant improvement was observed in ASFA2 (p > 0.05). In ASFA3, a significant improvement was observed in INR, AST, ALT, LDH, total bilirubin, creatinine, pH, and lactate values after TPE (p < 0.05). Five patients died from ASFA1, one from ASFA2, and three patients from ASFA3. Since significant adjustments are observed in clinical and laboratory values in sepsis-MOF, which is in the ASFA3 category, we believe that it should be evaluated in the ASFA2 or ASFA1 category in the early treatment of these diseases. In addition, we think that MIS-C cases, which have not been in any category according to ASFA, should be included in the ASFA2 or ASFA3 category, considering our TPE results.
Sections du résumé
Background/aim
UNASSIGNED
Therapeutic plasma exchange (TPE) is an extracorporeal treatment method that removes large molecular weight substances from plasma. In our study, we aimed to retrospectively examine the indications and procedural methods of the patients who had undergone TPE, and the complications that occurred during the procedure.
Materials and methods
UNASSIGNED
Forty-one patients who were monitored in thePICU of Gazi Yaşargil Training and Research Hospital and had indications for TPE between 2017 and 2021 were included in the study. Laboratory parameters were checked before and after the TPE procedure. In addition to these, patients' diagnosis, weight, type of procedure and type of device, where the procedure was performed, duration of the procedure, amount of blood and plasma processed, complications, number of procedures, and death during the procedure or independent of the procedure were evaluated.
Results
UNASSIGNED
The median age was 93.0 (14.0-167.0) months. Hemolytic uremic syndrome (HUS) was the most common TPE indication with nine patients. The most common complication related to TPE was fever (11 patients), while no complication was observed in 18 patients.When laboratory results were evaluated according to American Society for Apheresis (ASFA) categories, a significant improvement was observed in the values of platelet, AST, ALT, LDH, urea, and creatinine in ASFA1 after TPE. No significant improvement was observed in ASFA2 (p > 0.05). In ASFA3, a significant improvement was observed in INR, AST, ALT, LDH, total bilirubin, creatinine, pH, and lactate values after TPE (p < 0.05). Five patients died from ASFA1, one from ASFA2, and three patients from ASFA3.
Conclusion
UNASSIGNED
Since significant adjustments are observed in clinical and laboratory values in sepsis-MOF, which is in the ASFA3 category, we believe that it should be evaluated in the ASFA2 or ASFA1 category in the early treatment of these diseases. In addition, we think that MIS-C cases, which have not been in any category according to ASFA, should be included in the ASFA2 or ASFA3 category, considering our TPE results.
Identifiants
pubmed: 39050002
doi: 10.55730/1300-0144.5817
pii: tjmed-54-03-508
pmc: PMC11265844
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
508-516Informations de copyright
© TÜBİTAK.
Références
Ther Apher Dial. 2014 Oct;18(5):497-501
pubmed: 24674133
Turk Arch Pediatr. 2022 Mar;57(2):186-192
pubmed: 35383013
J Clin Apher. 2010;25(3):83-177
pubmed: 20568098
Anaesthesiol Intensive Ther. 2013 Jan-Mar;45(1):7-13
pubmed: 23572301
J Clin Apher. 2016 Jun;31(3):149-62
pubmed: 27322218
Haematologica. 2014 Oct;99(10):1547-54
pubmed: 25271314
Medicine (Baltimore). 2019 May;98(18):e15307
pubmed: 31045766
J Clin Apher. 2013 Feb;28(1):73-7
pubmed: 23420597
Lancet. 2011 Sep 17;378(9796):1089-93
pubmed: 21871657
World J Gastroenterol. 2020 Jan 14;26(2):219-245
pubmed: 31988586
Semin Dial. 2012 Mar-Apr;25(2):201-6
pubmed: 22353434
Clin J Am Soc Nephrol. 2014 Jan;9(1):181-90
pubmed: 24178973
J Hepatol. 2016 Jan;64(1):69-78
pubmed: 26325537
Transfus Apher Sci. 2013 Jun;48(3):375-6
pubmed: 23685078
J Clin Apher. 2011;26(5):230-8
pubmed: 21882233
J Clin Apher. 2019 Jun;34(3):171-354
pubmed: 31180581